GoodRx Holdings, Inc.
GDRX
$3.44
-$0.01-0.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.30% | -0.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.30% | -0.40% | |||
| Cost of Revenue | 4.18% | 15.41% | |||
| Gross Profit | 3.20% | -1.96% | |||
| SG&A Expenses | -0.99% | 17.30% | |||
| Depreciation & Amortization | 2.19% | -5.85% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.79% | 14.06% | |||
| Operating Income | 68.69% | -62.11% | |||
| Income Before Tax | 174.27% | -60.27% | |||
| Income Tax Expenses | 55.03% | -49.02% | |||
| Earnings from Continuing Operations | 630.20% | -78.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 630.20% | -78.45% | |||
| EBIT | 68.69% | -62.11% | |||
| EBITDA | 28.21% | -40.45% | |||
| EPS Basic | 641.18% | -78.62% | |||
| Normalized Basic EPS | 176.70% | -80.31% | |||
| EPS Diluted | 488.24% | -78.62% | |||
| Normalized Diluted EPS | 169.90% | -80.27% | |||
| Average Basic Shares Outstanding | -0.37% | 0.10% | |||
| Average Diluted Shares Outstanding | 1.94% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||